IL200449A0 - Triol form of rosuvastatin - Google Patents

Triol form of rosuvastatin

Info

Publication number: IL200449A0
Authority: IL; Israel
Prior art keywords: rosuvastatin; triol form; triol
Prior art date: 2007-03-13

Application number

IL200449A

Other languages

English (en)

Original Assignee

Teva Pharma

Balanov Anna

Niddam Hildesheim Valerie

Veinberg Irena

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-03-13

Filing date

2009-08-18

Publication date

2010-04-29

2009-08-18 Application filed by Teva Pharma, Balanov Anna, Niddam Hildesheim Valerie, Veinberg Irena filed Critical Teva Pharma

2010-04-29 Publication of IL200449A0 publication Critical patent/IL200449A0/en

Links

BPRHUIZQVSMCRT-VEUZHWNKSA-N rosuvastatin Chemical compound CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O BPRHUIZQVSMCRT-VEUZHWNKSA-N 0.000 title 1
229960000672 rosuvastatin Drugs 0.000 title 1
150000004072 triols Chemical group 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Hematology (AREA)
Diabetes (AREA)
Obesity (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Investigating Or Analysing Biological Materials (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Plural Heterocyclic Compounds (AREA)

IL200449A 2007-03-13 2009-08-18 Triol form of rosuvastatin IL200449A0 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US90691407P	2007-03-13	2007-03-13
US91846607P	2007-03-15	2007-03-15
PCT/US2008/003470 WO2008112317A2 (fr)	2007-03-13	2008-03-13	Forme triol de rosuvastatine

Publications (1)

Publication Number	Publication Date
IL200449A0 true IL200449A0 (en)	2010-04-29

Family

ID=39650560

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL200449A IL200449A0 (en)	2007-03-13	2009-08-18	Triol form of rosuvastatin

Country Status (8)

Country	Link
EP (1)	EP2121631A2 (fr)
JP (1)	JP5330225B2 (fr)
KR (1)	KR100945760B1 (fr)
BR (1)	BRPI0803085A2 (fr)
CA (1)	CA2680604C (fr)
IL (1)	IL200449A0 (fr)
MX (1)	MX2008014552A (fr)
WO (1)	WO2008112317A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2576518B1 (fr) *	2010-06-07	2016-08-10	Pharmathen S.A.	Procédé amélioré pour la préparation d'intermédiaire propénal et dérivés de celui-ci
CN112782333B (zh) *	2020-12-25	2022-07-12	石家庄四药有限公司	一种匹伐他汀异丙基叔丁酯非对映异构体的hplc检测方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1894221B (zh) *	2003-12-02	2012-08-08	特瓦制药工业有限公司	用于表征罗苏伐他汀的参照标准品

2008
- 2008-03-13 JP JP2009504512A patent/JP5330225B2/ja not_active Expired - Fee Related
- 2008-03-13 BR BRPI0803085-5A patent/BRPI0803085A2/pt not_active IP Right Cessation
- 2008-03-13 MX MX2008014552A patent/MX2008014552A/es active IP Right Grant
- 2008-03-13 WO PCT/US2008/003470 patent/WO2008112317A2/fr not_active Ceased
- 2008-03-13 KR KR1020087027688A patent/KR100945760B1/ko not_active Expired - Fee Related
- 2008-03-13 CA CA2680604A patent/CA2680604C/fr not_active Expired - Fee Related
- 2008-03-13 EP EP08726880A patent/EP2121631A2/fr not_active Withdrawn
2009
- 2009-08-18 IL IL200449A patent/IL200449A0/en unknown

Also Published As

Publication number	Publication date
EP2121631A2 (fr)	2009-11-25
WO2008112317A2 (fr)	2008-09-18
KR20090010195A (ko)	2009-01-29
CA2680604A1 (fr)	2008-09-18
KR100945760B1 (ko)	2010-03-08
WO2008112317A3 (fr)	2008-11-06
JP2009519353A (ja)	2009-05-14
JP5330225B2 (ja)	2013-10-30
BRPI0803085A2 (pt)	2011-08-30
CA2680604C (fr)	2012-08-07
MX2008014552A (es)	2009-03-09

Publication	Publication Date	Title
EP2185570A4 (fr)	2011-02-09	Nouveaux activateurs de glucokinase
EP2191397A4 (fr)	2016-03-30	Rejet amélioré de mots hors vocabulaire
IL219133A0 (en)	2012-06-28	Antimicrobial compounds and methods of making and using the same
IL216973A0 (en)	2012-02-29	Heterocyclic compounds and their uses
ZA200903533B (en)	2010-03-31	Process for the preparation of rosuvastatin
IL219135A0 (en)	2012-06-28	Antimicrobial compounds and methods of making and using the same
ZA201105986B (en)	2012-08-29	Substituted pyrimidines for the treatment of cancer
ZA201106585B (en)	2012-11-28	Pyrimidine compound
IL257837A (en)	2018-04-30	Antimicrobial compounds and methods for their preparation and use
AP2008004406A0 (en)	2008-04-30	Methods of managing timberland
ZA201102604B (en)	2012-09-26	Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
ZA201107053B (en)	2014-03-26	Use of rosuvastatin lactols as medicaments
SI2387566T1 (sl)	2014-07-31	Postopek za pripravo rosuvastatina
PL2133419T3 (pl)	2019-02-28	Zastosowania beta-dipeptydów cyjanoficyny
PL2328545T3 (pl)	2016-04-29	Zastosowanie glukozyloglicerolu
PH12012500732A1 (en)	2020-10-19	Antimicrobial compounds and methods of making and using the same
EP2328873A4 (fr)	2011-09-07	Préparation de ranolazine
AP2784A (en)	2013-10-31	Methods of managing timberland
PL2233133T3 (pl)	2012-12-31	Trwałe kompozycje rozuwastatyny
PL2237782T3 (pl)	2018-12-31	Zastosowanie tetrahydropirymidyn
IL200449A0 (en)	2010-04-29	Triol form of rosuvastatin
GB201114396D0 (en)	2011-10-05	Location of basesation
GB0703514D0 (en)	2007-04-04	Use of riboflavin
PL384673A1 (pl)	2009-09-14	Zestaw podokładzinowych listew dekoracyjnych
PL381510A1 (pl)	2008-07-21	Sposób otrzymywania nowych pirymidynowych azanukleozydów